0001689813-20-000073 Sample Contracts

AutoNDA by SimpleDocs
Funding Agreement By and Between Biohaven Pharmaceutical Holding Company Ltd. and RPI 2019 Intermediate Finance Trust Dated as of August 7, 2020
Funding Agreement • November 9th, 2020 • Biohaven Pharmaceutical Holding Co Ltd. • Pharmaceutical preparations • New York
AMENDMENT NO. 1 TO FUNDING AGREEMENT
Funding Agreement • November 9th, 2020 • Biohaven Pharmaceutical Holding Co Ltd. • Pharmaceutical preparations • New York

This Amendment No. 1 to Funding Agreement (this “Amendment”), is entered into on August 7, 2020, by and between Biohaven Pharmaceutical Holding Company Ltd., a business company organized under the laws of the British Virgin Islands (the “Seller”), Biohaven Pharmaceuticals Ireland DAC, a designated activity company organized under the laws of Ireland (“BPID”, and together with the Seller, the “Seller Entities”), and RPI Finance Trust, a Delaware statutory trust (the “Buyer”) and amends that certain Funding Agreement dated June 18, 2018 (the “Funding Agreement”) by and between the Seller and the Buyer. Capitalized terms used and not otherwise defined herein shall have the meaning ascribed to such terms in the Funding Agreement.

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. SERIES B PREFERRED SHARE PURCHASE AGREEMENT
Series B Preferred Share Purchase Agreement • November 9th, 2020 • Biohaven Pharmaceutical Holding Co Ltd. • Pharmaceutical preparations • New York

THIS SERIES B PREFERRED SHARE PURCHASE AGREEMENT (the “Agreement”) is made as of August 7, 2020 (the “Execution Date”) by and between Biohaven Pharmaceutical Holding Company Ltd., a BVI business company organized under the laws of the British Virgin Islands (the “Company”), and RPI 2019 Intermediate Finance Trust, a Delaware statutory trust (the “Investor”).

Time is Money Join Law Insider Premium to draft better contracts faster.